| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/30/2009 | US7553668 transgenic plant; host cell; isolated nucleic acid molecule; nucleic acid sequences encoding the coat protein ; DNA expression vector; disease resistance |
| 06/30/2009 | US7553667 one or more nucleotide sequences of interest in transgenic plants; fusion proteins comprising a DNA binding domain fused to a recruitment factor that is capable of recruiting chromatin remodelling proteins such as HDAC and HAT, to specific DNA sites to regulate expression of a gene of interest |
| 06/30/2009 | US7553665 alternative media free from animal sources; Chinese hamster ovary (CHO) cells; Asparagine, Sodium Chloride, Selenite, Wheat hydrolysate and Insulin |
| 06/30/2009 | US7553664 Methods for cultivating dermal fibroblasts, methods for preparing in vitro dermis equivalents, methods for preparing three-dimensional in vitro skin equivalents, an in vitro dermis equivalent, a three dimensional in vitro skin |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553662 Propagating bone and cartilage-forming cells in pulsed magnetic field; in vitro cultivation of replacement tissue for humans and animals; tissue engineering and repair; bioreactors |
| 06/30/2009 | US7553661 interferon.gamma. (IFN.gamma.) stimulated stromal antigen-presenting cell expresses MHC II, B7-H1 and/or CD80; used to generate an immune response |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553659 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 06/30/2009 | US7553648 Cytochrome P450 monooxygenases consisting of thermophilic bacteria |
| 06/30/2009 | US7553644 Detection and treatment of polycystic kidney disease |
| 06/30/2009 | US7553641 Tumour necrosis factor binding ligands |
| 06/30/2009 | US7553637 Using expression vector comprising nucleotide sequences coding membrane insertion protein as tool in improving exogenous gene expression in host cells |
| 06/30/2009 | US7553613 Coagulation, mechanical agitation; filtration |
| 06/30/2009 | US7553494 WT1 fusion proteins |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553484 Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2445295C .beta.1,3-galactosyltransferase and dna encoding the same |
| 06/30/2009 | CA2437656C Polynucleotide constructs for increased lysine production |
| 06/30/2009 | CA2359318C Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/25/2009 | WO2009079606A2 Microrna-induced es-like cells and uses thereof |
| 06/25/2009 | WO2009079508A1 Methods and compositions for reducing stress in plants |
| 06/25/2009 | WO2009079489A1 Methods for screening of opioid receptor neutral antagonists and inverse agonists and uses thereof |
| 06/25/2009 | WO2009079431A1 Breast reconstruction or augmentation using computer-modeled deposition of processed adipose tissue |
| 06/25/2009 | WO2009079409A1 Cell culture matrices |
| 06/25/2009 | WO2009079383A1 Systems, methods, and devices for blood treatment |
| 06/25/2009 | WO2009079007A1 Stem-like cells and method for reprogramming adult mammalian somatic cells |
| 06/25/2009 | WO2009078977A2 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 06/25/2009 | WO2009077973A1 Expression cassettes and methods for increasing plant yield |
| 06/25/2009 | WO2009077430A1 Method for reprogramming in vitro stem cells and somatic cells into germinal cells |
| 06/25/2009 | WO2009077134A2 Use of rna for reprogramming somatic cells |
| 06/25/2009 | WO2009076711A1 Enzymes and methods for degrading chlorinated s-triazines |
| 06/25/2009 | WO2009054939A3 Cancer classification and methods of use |
| 06/25/2009 | WO2009046123A3 Nlrr-1 antagonists and uses thereof |
| 06/25/2009 | WO2009036228A3 Hepatitis b pre-s2 nucleic acid |
| 06/25/2009 | WO2009029937A8 Methods and assays for screening stem cells |
| 06/25/2009 | WO2009022907A3 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 06/25/2009 | WO2009009591A9 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 06/25/2009 | WO2008151846A3 T cell immunomodulation by placenta cell preparations |
| 06/25/2009 | US20090165176 Artificial Plant Minichromosomes |
| 06/25/2009 | US20090165173 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
| 06/25/2009 | US20090165171 Transgenic Plants Exhibiting Increased Tolerance to Stress and Methods of Generating Same |
| 06/25/2009 | US20090165170 Phosphatase Stress-Related Proteins and Methods of Use in Plants |
| 06/25/2009 | US20090165169 regulate the proanthocynanidin biosynthetic pathway and proanthocynanidin biosynthesis in a plant; genetic engineering; |
| 06/25/2009 | US20090165167 Means and Methods to Enhance the Production of Vinblastine and Vincristine in Catharanthus Roseus |
| 06/25/2009 | US20090165165 Transgenic plants with enhanced agronomic traits |
| 06/25/2009 | US20090165155 Tissue Specific Expression of Exogenous Proteins in Transgenic Chickens |
| 06/25/2009 | US20090165154 Genetically engineered ungulates for use as bioreactors for human antibodies; reducing transmission of spongiform encephalopy |
| 06/25/2009 | US20090165153 Modified gene-silencing RNA and uses thereof |
| 06/25/2009 | US20090165152 Mesothelin Vaccines and Model Systems |
| 06/25/2009 | US20090165151 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators |
| 06/25/2009 | US20090163612 Tissue engineering scaffold |
| 06/25/2009 | US20090163595 Method of Modulating Membrane Potential of a Cell |
| 06/25/2009 | US20090163594 Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors |
| 06/25/2009 | US20090163592 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/25/2009 | US20090163578 Novel modification of immunomodulatory protein |
| 06/25/2009 | US20090163564 Translational Dysfunction Based Therapeutics |
| 06/25/2009 | US20090163563 Phorboxazole Compounds and Methods of Their Preparation |
| 06/25/2009 | US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 06/25/2009 | US20090163511 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 06/25/2009 | US20090163476 N-Phenyl Benzamide Derivatives as Sirtuin Modulators |
| 06/25/2009 | US20090163430 Functions and targets of let-7 micro rnas |
| 06/25/2009 | US20090163407 Compositions and methods for altering wnt autocrine signaling |
| 06/25/2009 | US20090163406 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 06/25/2009 | US20090163376 Ketol-acid reductoisomerase using nadh |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162934 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| 06/25/2009 | US20090162933 Epha2 and hyperproliferative cell disorders |
| 06/25/2009 | US20090162932 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 06/25/2009 | US20090162931 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/25/2009 | US20090162918 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant |
| 06/25/2009 | US20090162917 Subtilism Carlsberg Proteins With Reduced Immunogencity |
| 06/25/2009 | US20090162915 Peptidylarginine Deiminase 6 |
| 06/25/2009 | US20090162906 Biocatalysts; mutant and/or chemically modified enzymes; stereoselectively hydrolyze an amino nitrile or cyanohydrin intermediate to produce the corresponding carboxylic acid; e.g. phenylglycinonitrile from benzaldehyde, potassium cyanide and ammonium chloride |
| 06/25/2009 | US20090162904 Transgenic plants and methods for controlling bolting in sugar beet |
| 06/25/2009 | US20090162902 Monoclonal antibody that binds protein A from Staphylococcus aureus; use in diagnosis, therapy and detection |
| 06/25/2009 | US20090162900 Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such of such products |
| 06/25/2009 | US20090162894 A gene encoding a protein having an improved nitrile hydratase activity, whereby heat resistance has been improved or substrate specificity has been changed; for efficient production of acrylamide |
| 06/25/2009 | US20090162893 Alcohol dehydrogenase for the stereoselective production of hydroxy compounds |
| 06/25/2009 | US20090162889 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| 06/25/2009 | US20090162887 Particle analysis in an acoustic cytometer |
| 06/25/2009 | US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 06/25/2009 | US20090162869 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 06/25/2009 | US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 06/25/2009 | US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
| 06/25/2009 | US20090162831 human parvovirus |
| 06/25/2009 | US20090162458 Compositions and methods for inducing the expression of heat shock proteins |
| 06/25/2009 | US20090162452 EB Matrix Production From Animal Tissue And Its Use For Tissue Repair |
| 06/25/2009 | US20090162437 Modified self-assembling peptides |
| 06/25/2009 | US20090162404 Tumor vaccine |
| 06/25/2009 | US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/25/2009 | US20090162388 epitope of salmonid alphaviruses capable of inducing a virus neutralizing immune response |
| 06/25/2009 | US20090162380 Multispecific binding molecules comprising connecting peptides |